Evidence map›Paper›PMID 24738626›Full record

ArticleNano letters2014

Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors.

Jonathan R McDaniel, Sarah R MacEwan, Xinghai Li, D Christopher Radford, Chelsea D Landon, Mark Dewhirst, Ashutosh Chilkoti

Open access · bronzeAbstract read
In one paragraph

Article in Nano letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Self-assembling prodrugs.Chemical Society reviews · 2017
    Review
  11. Review
  12. Article
  13. Review
  14. Anticancer nanoparticulate polymer-drug conjugate.Bioengineering & translational medicine · 2016
    Review
  15. Article
  16. Article
  17. One-component nanomedicine.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  18. Fabrication of thermo-sensitive complex micelles for reversible cell targeting.Journal of materials science. Materials in medicine · 2015
    Article
  19. Article
  20. An amphipathic alpha-helical peptide from apolipoprotein A1 stabilizes protein polymer vesicles.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jonathan R McDanielDepartment of Biomedical Engineering, Duke University , Durham, North Carolina 27708-0281, United States.
Sarah R MacEwan
Xinghai Li
D Christopher Radford
Chelsea D Landon
Mark Dewhirst
Ashutosh Chilkoti
Duke University · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Thermally Targeted Drug Delivery by Elastin BiopolymersR01EB000188 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2002 to 2015
$3.9M
Thermally Triggered Multivalent Targeting of TumorsR01EB007205 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2007 to 2015
$2.7M
NCI NIH HHS P30 CA014236NIBIB NIH HHS R01 EB000188NIBIB NIH HHS R01 EB007205
6 · The paper itself

Abstract

This paper demonstrates the first example of targeting a solid tumor that is externally heated to 42 °C by "heat seeking" drug-loaded polypeptide nanoparticles. These nanoparticles consist of a thermally responsive elastin-like polypeptide (ELP) conjugated to multiple copies of a hydrophobic cancer drug. To rationally design drug-loaded nanoparticles that exhibit thermal responsiveness in the narrow temperature range between 37 and 42 °C, an analytical model was developed that relates ELP composition and chain length to the nanoparticle phase transition temperature. Suitable candidates were designed based on the predictions of the model and tested in vivo by intravital confocal fluorescence microscopy of solid tumors, which revealed that the nanoparticles aggregate in the vasculature of tumors heated to 42 °C and that the aggregation is reversible as the temperature reverts to 37 °C. Biodistribution studies showed that the most effective strategy to target the nanoparticles to tumors is to thermally cycle the tumors between 37 and 42 °C. These nanoparticles set the stage for the targeted delivery of a range of cancer chemotherapeutics by externally applied mild hyperthermia of solid tumors.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorColonic NeoplasmsDrug Delivery SystemsElastinHumansHyperthermia, InducedMiceNanoparticlesPeptidesTemperatureAntineoplastic AgentsElastinPeptides

Identifiers

PMID24738626
PMCPMC4025578
OpenAlexW2334265885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.